| Literature DB >> 24979594 |
Bruna Puty1, Caio Maximino, Alódia Brasil, Waldo Lucas Luz da Silva, Amauri Gouveia, Karen Renata Matos Oliveira, Evander de Jesus Oliveira Batista, Maria Elena Crespo-Lopez, Fernando Allan F Rocha, Anderson Manoel Herculano.
Abstract
To evaluate the protector effect of ascorbic acid (AA) against anxiogenic-like effect induced by methylmercury (MeHg) exposure, adult zebrafish were treated with AA (2 mg g(-1), intraperitoneal [i.p.]) before MeHg administration (1.0 μg g(-1), i.p.). Groups were tested for the light/dark preference as a behavioral model of anxiety, and the content of serotonin and its oxidized metabolite tryptamine-4,5-dione (T-4,5-D) in the brain was determined by high-performance liquid chromatography. MeHg has produced a marked anxiogenic profile in both tests, and this effect was accompanied by a decrease in the extracellular levels of serotonin, and an increase in the extracellular levels of T-4,5-D. Added to this, a marked increase in the formation of a marker of oxidative stress accompanied these parameters. Interestingly, the anxiogenic-like effect and biochemical alterations induced by MeHg were blocked by pretreatment with AA. These results for the first time demonstrated the potential protector action of AA in neurobehavioral and neurochemical alterations induced by methylmecury exposure demonstrating that zebrafish model could be used as an important tool for testing substances with neuroprotector actions.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24979594 DOI: 10.1089/zeb.2013.0947
Source DB: PubMed Journal: Zebrafish ISSN: 1545-8547 Impact factor: 1.985